Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Xeomin for the Treatment of Notalgia Paresthetica

NCT01098019 is registered in ClinicalTrials.gov with Innovaderm Research Inc. as lead sponsor.

NCT NCT01098019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01098019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Xeomin for the Treatment of Notalgia Paresthetica
Lead sponsor
Innovaderm Research Inc.
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2010
Completion date
February 29, 2012
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

notalgia paresthetica